"Designing Growth Strategies is in our DNA"

North America AI in Pharma & Biotech Market Size, Share & Industry Analysis, By Technology (Machine Learning & Deep Learning, Natural Language Processing, and Others), By Application (Drug Discovery & Development, Clinical Research & Optimization, Precision Medicine, Pharmaceutical Manufacturing, and Operations & Medical Affairs), By End-User (Pharmaceutical & Biotechnology Companies, CDMOs & CROs, and Others), and Regional Forecast, 2025-2032

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI112084

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. New Product Launches, By Key Players
    2. Overview: Advancements in AI in Pharma & Biotech
    3. Guidelines/Consideration for Using Artificial Intelligence (AI) in Pharma & Biotech
    4. Key Industry Developments - (Mergers, Acquisitions, Partnerships, etc.)
    5. Overview of Investment Trends
    6. Key Challenges in the Industry
    7. Overview: Influence of Trump Administration on the Industry
    8. Impact of COVID-19 on the Market
    9. Overview on the M&A Trends in the AI in Pharma & Biotech Market
  5. North America AI in Pharma & Biotech Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Technology
      1. Machine Learning & Deep Learning
      2. Natural Language Processing
      3. Others
    2. Market Analysis, Insights and Forecast – By Application
      1. Drug Discovery & Development
      2. Clinical Research & Optimization
      3. Precision Medicine
      4. Pharmaceutical Manufacturing
      5. Operations & Medical Affairs
    3. Market Analysis, Insights and Forecast – By End User
      1. Pharmaceutical & Biotechnology Companies
      2. CDMOs & CROs
      3. Others
    4. Market Analysis, Insights and Forecast – By Country
      1. U.S.
        1. By Technology
        2. By Application
        3. By End User
      2. Canada
  6. Competitive Analysis
    1. North America Market Share Analysis (2024)
    2. Company Profiles
      1. Insilico Medicine
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. Atomwise Inc.
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. BPGbio, Inc.
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. IBM
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. Code Ocean
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. Recursion
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      7. Cloud
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      8. ReviveMed Inc.
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      9. NVIDIA Corporation
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. New Product Launches, By Key Players
    2. Overview: Advancements in AI in Pharma & Biotech
    3. Guidelines/Consideration for Using Artificial Intelligence (AI) in Pharma & Biotech
    4. Key Industry Developments - (Mergers, Acquisitions, Partnerships, etc.)
    5. Overview of Investment Trends
    6. Key Challenges in the Industry
    7. Overview: Influence of Trump Administration on the Industry
    8. Impact of COVID-19 on the Market
    9. Overview on the M&A Trends in the AI in Pharma & Biotech Market
  5. North America AI in Pharma & Biotech Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Technology
      1. Machine Learning & Deep Learning
      2. Natural Language Processing
      3. Others
    2. Market Analysis, Insights and Forecast – By Application
      1. Drug Discovery & Development
      2. Clinical Research & Optimization
      3. Precision Medicine
      4. Pharmaceutical Manufacturing
      5. Operations & Medical Affairs
    3. Market Analysis, Insights and Forecast – By End User
      1. Pharmaceutical & Biotechnology Companies
      2. CDMOs & CROs
      3. Others
    4. Market Analysis, Insights and Forecast – By Country
      1. U.S.
        1. By Technology
        2. By Application
        3. By End User
      2. Canada
  6. Competitive Analysis
    1. North America Market Share Analysis (2024)
    2. Company Profiles
      1. Insilico Medicine
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. Atomwise Inc.
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. BPGbio, Inc.
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. IBM
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. Code Ocean
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. Recursion
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      7. Cloud
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      8. ReviveMed Inc.
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      9. NVIDIA Corporation
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
Read Less

Table 01: North America AI in Pharma & Biotech Market Revenue (USD billion) Forecast, By Technology, 2019 –2032

Table 02: North America AI in Pharma & Biotech Market Revenue (USD billion) Forecast, By Application, 2019 –2032

Table 03: North America AI in Pharma & Biotech Market Revenue (USD billion) Forecast, By End User, 2019–2032

Table 04: North America AI in pharma & biotech market Revenue (USD billion) Forecast, By Country, 2019–2032

Table 05: U.S. AI in Pharma & Biotech Market Revenue (USD billion) Forecast, By Technology, 2019–2032

Table 06: U.S. AI in Pharma & Biotech Market Revenue (USD billion) Forecast, By Application, 2019–2032

Table 07: U.S. AI in Pharma & Biotech Market Revenue (USD billion) Forecast, By End User, 2019–2032

Figure 01: North America AI in Pharma & Biotech Market Revenue Breakdown (USD billion, %) by Country, 2024 & 2032

Figure 02: North America AI in Pharma & Biotech Market Value Share (%), By Technology, 2024 & 2032

Figure 03: North America AI in Pharma & Biotech Market Value Share (%), By Application, 2024 & 2032

Figure 04: North America AI in Pharma & Biotech Market Value Share (%), By End User, 2024 & 2032

Figure 05: North America AI in Pharma & Biotech Market Value Share (%), By Country, 2024 & 2032

Figure 06: North America AI in Pharma & Biotech Market Share Analysis (%), 2024

North America AI in Pharma & Biotech Market
  • 2019-2032
  • 2024
  • 2019-2023
  • 100
Download Free Sample

    man icon
    Mail icon
    Captcha refresh
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports